AVANOS MEDICAL, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Avanos Medical, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2014 to Q2 2024.
  • Avanos Medical, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 45.9M shares, a 1.92% decline year-over-year.
  • Avanos Medical, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 46.6M shares, a 0.64% decline from 2022.
  • Avanos Medical, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 46.9M shares, a 2.5% decline from 2021.
  • Avanos Medical, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 48.1M shares, a 0.63% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 45.9M -900K -1.92% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 46.2M -400K -0.86% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 46.6M -300K -0.64% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 46.8M +200K +0.43% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 46.8M -400K -0.85% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 46.6M -800K -1.69% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 46.9M -1.2M -2.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 46.6M -1.5M -3.12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 47.2M -900K -1.87% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 47.4M -600K -1.25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 48.1M +300K +0.63% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 48.1M +300K +0.63% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 48.1M +300K +0.63% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 48M +200K +0.42% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 47.8M +200K +0.42% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 47.8M +100K +0.21% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 47.8M +200K +0.42% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 47.8M +300K +0.63% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 47.6M +400K +0.85% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 47.7M +400K +0.85% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 47.6M +500K +1.06% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 47.5M +600K +1.28% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 47.2M +400K +0.86% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 47.3M +500K +1.07% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 47.1M +400K +0.86% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 46.9M +200K +0.43% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 46.8M +200K +0.43% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 46.8M +100K +0.21% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-12-17
Q2 2017 46.7M 0 0% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 46.7M +100K +0.22% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 46.6M 0 0% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 46.7M +100K +0.22% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 46.7M +100K +0.22% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 46.6M +100K +0.22% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 46.6M +100K +0.22% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 46.6M +100K +0.22% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 46.6M +100K +0.22% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 46.5M 0 0% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 46.5M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 46.5M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 46.5M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 46.5M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.